Invest now
Max Healthcare Institute share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹1,010.05(-0.36%)August 19, 2026 10:39:01 AM IST
- NSE
- BSE
- Vol : 204.87 K (NSE + BSE)Last 20 day avg : 2.23 M
Max Healthcare Institute is trading -0.36% lower at Rs 1,010.05 as compared to its last closing price. Max Healthcare Institute has been trading in the price range of 1,016.25 & 1,003.50. Max Healthcare Institute has given -2.94% in this year & -2.46% in the last 5 days. Max Healthcare Institute has TTM P/E ratio 75.28 as compared to the sector P/E of 20.23.There are 25 analysts who have initiated coverage on Max Healthcare Institute. There are 7 analysts who have given it a strong buy rating & 12 analysts have given it a buy rating. 4 analysts have given the stock a sell rating.The company posted a net profit of 322.49 Crores in its last quarter.Listed peers of Max Healthcare Institute include Apollo Hospitals Enterprise (0.47%), Fortis Healthcare (0.35%), Aster DM Healthcare (1.55%).The Mutual Fund holding in Max Healthcare Institute was at 18.68% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Max Healthcare Institute was at 41.78% in 30 Jun 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 19 Aug 2026, 10:40 AM IST
- BetaLow volatility0.84Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityIn line with industry0.32The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.20Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation7.20The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Max Healthcare Institute News
Max Healthcare Institute Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | 8,859.15 | 0.47 | 1,27,380.98 | 64.93 | 13.39 | 0.23 | 53.80 |
| Fortis Healthcare | 919.25 | 0.35 | 69,399.53 | 67.89 | 7.27 | 0.10 | 29.68 |
| Aster DM Healthcare | 830.50 | 1.55 | 72,268.68 | 102.55 | 9.26 | 0.49 | 44.74 |
| Narayana Hrudayalaya | 1,803.80 | 0.07 | 36,822.77 | 48.07 | 9.08 | 0.22 | 121.59 |
| Global Health | 1,440.05 | -0.13 | 38,557.11 | 63.65 | 8.93 | 0.04 | 28.45 |
Mutual Fund Ownership
View allMax Healthcare Institute Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-05-21 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
About the company Max Healthcare Institute
- IndustryHealthcare Facilities
- ISININE027H01010
- BSE Code543220
- NSE CodeMAXHEALTH
Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company offers an integrated suite of diagnostics and lab services, ambulatory care, consultations, surgical and non-surgical procedures, and medical treatment. Its clinical offerings span a range of therapeutic areas, including radiation therapy for cancer, and specialized treatments in oncology, neurosciences, cardiac sciences, orthopedics, renal and liver care and minimally invasive surgery. It also provides consultations across diverse medical specialties such as diabetes and endocrinology, pulmonology, nephrology, dermatology, gastroenterology, physiotherapy and rehabilitation. It also caters to specific healthcare needs, including transplant services, audiology and speech therapy, and dedicated pediatric care. It offers a home care program through Max@Home, enabling patients to receive medical attention in the comfort of their homes. Its Max Lab provides at-home diagnostic testing.
Max Healthcare Institute Share Price FAQs
Max Healthcare Institute is trading at 1010.05 as on Wed Aug 19 2026 05:09:01. This is -0.36% lower as compared to its previous closing price of 1013.65.
The market capitalization of Max Healthcare Institute is 98305.48 Cr as on Wed Aug 19 2026 05:09:01.
The average broker rating on Max Healthcare Institute is Buy. The breakup of analyst rating is given below -
- 7 analysts have given a strong buy rating
- 12 analysts have given a buy rating
- 2 analysts have given a hold rating
- 4 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Max Healthcare Institute is 1258.95 whereas the 52 wk low is 903.50
Max Healthcare Institute can be analyzed on the following key metrics -
- TTM P/E: 75.28
- Sector P/E: 20.23
- Dividend Yield: 0.20%
- D/E ratio: -
Max Healthcare Institute reported a net profit of 1442.41 Cr in 2026.
The Mutual Fund Shareholding was 18.68% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Max Healthcare Institute QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.